NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
2 | 2D 1H-15N HSQC | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
3 | 2D 1H-15N HSQC | 3.75 mM CALCIUM ION, 1.47 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 0.6 mM V5-pHM peptide | 92% H2O/8% D2O | 0.077 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
4 | 2D 1H-13C HSQC aliphatic | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
5 | 2D 1H-13C HSQC aliphatic | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
6 | 2D 1H-13C HSQC aromatic | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
10 | 3D C(CO)NH | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
9 | 3D H(CCO)NH | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
8 | 3D HCCH-TOCSY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
7 | 3D HCCH-COSY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
11 | 3D aromatic HCCH-TOCSY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
12 | 3D 1H-13C NOESY aliphatic | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
13 | 3D 1H-15N NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
14 | 2D [F2-15N,13C filtered] NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
15 | 2D [F2-15N,13C filtered] NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
16 | 2D [F1,F2-15N,13C filtered] NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
17 | 2D [F1,F2-15N,13C filtered] NOESY | 3.75 mM CALCIUM ION, 1.47 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 0.6 mM V5-pHM peptide | 92% H2O/8% D2O | 0.077 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
18 | 2D [F1,F2-15N,13C filtered] TOCSY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
19 | 2D [F1,F2-15N,13C filtered] TOCSY | 3.75 mM CALCIUM ION, 1.47 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 0.6 mM V5-pHM peptide | 92% H2O/8% D2O | 0.077 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 500 |
20 | 3D [F1-15N,13C filtered] 1H-15N NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 92% H2O/8% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |
21 | 3D [F1-15N,13C filtered] 1H-13C NOESY | 2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2 domain of protein kinase C alpha, 6.7 mM MES, 67 mM potassium chloride, 0.2 mg/mL sodium azide, 2 mM V5-pHM peptide | 100% D2O | 0.076 M | 6.0 | 1 atm | 296.15 | Bruker AVANCE III 800 |